Ontak Treatment Can Lead To Color Vision Loss, Company Warns

Loss of visual acuity has been reported in some patients treated with the oncologic, according to a new warning added to labeling and a "Dear Doctor" letter.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet